Research map: Effects of lavender oil preparation silexan on different symptoms of major depression – results from a randomized, controlled trial

Back to the article

Papers in this map

  1. Diagnostic and Statistical Manual of Mental Disorders · Andrés Santiago González Moreno · 2013 · 116742 citations · Cited by this paper
  2. A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorder · 2025 · Related
  3. A New Depression Scale Designed to be Sensitive to Change · Stuart Montgomery · 1979 · 14136 citations · Cited by this paper
  4. Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders · 2025 · Related
  5. Development of a Rating Scale for Primary Depressive Illness · Max Hamilton · 1967 · 8507 citations · Cited by this paper
  6. Responsible artificial intelligence integration framework for psychiatric guidelines · 2026 · Related
  7. Network analysis of depression and anxiety symptom relationships in a psychiatric sample · Courtney Beard · 2016 · 979 citations · Cited by this paper
  8. 291. USING MINOR PHYSICAL ANOMALIES TO PREDICT TREATMENT RESISTANCE IN SCHIZOPHRENIA PATIENTS THROUGH MACHINE LEARNING · 2025 · Related
  9. Effects of Antidepressants on Sleep · Adam Wichniak · 2017 · 529 citations · Cited by this paper
  10. Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosis · 2025 · Related
  11. The Montgomery‐Åsberg Depression Scale: reliability and validity · Jonathan R. T. Davidson · 1986 · 311 citations · Cited by this paper
  12. Exploring the association between sweet liking and treatment response to naltrexone in patients with alcohol use disorder · 2026 · Related
  13. Co‐morbidity between mood and anxiety disorders: A systematic review and meta‐analysis · Sukanta Saha · 2020 · 259 citations · Cited by this paper
  14. Modulatory effects of GLT-1 enhancer, MC-100093, on glutamate uptake and associated signaling pathways in female and male alcohol preferring rats exposed to ethanol · 2025 · Related
  15. Do p Values Lose Their Meaning in Exploratory Analyses? It Depends How You Define the Familywise Error Rate · Mark Rubin · 2017 · 226 citations · Cited by this paper
  16. High-density EEG study in patients with schizophrenia treated with cariprazine · 2026 · Related
  17. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder: a randomized, double-blind, placebo controlled trial · Siegfried F. Kasper · 2010 · 174 citations · Cited by this paper
  18. Sex-specific prolactin disturbance and divergent gonadal hormone correlates in first-episode schizophrenia · 2025 · Related
  19. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders · Borwin Bandelow · 2022 · 156 citations · Cited by this paper
  20. Psychostimulant effects on motor and cognitive function in adults attention deficit hyperactivity disorder · 2026 · Related
  21. The symptom‐specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta‐analysis · Lynn Boschloo · 2019 · 142 citations · Cited by this paper
  22. The structure of the Montgomery–Åsberg depression rating scale over the course of treatment for depression · Lena Catherine Quilty · 2013 · 140 citations · Cited by this paper
  23. Is the significant superiority of escitalopram compared with other antidepressants clinically relevant? · Stuart Montgomery · 2009 · 121 citations · Cited by this paper
  24. The clinical relevance of changes in the Montgomery–Asberg Depression Rating Scale using the minimum clinically important difference approach · Gérard Duru · 2008 · 114 citations · Cited by this paper
  25. Lavender essential oil ameliorates depression-like behavior and increases neurogenesis and dendritic complexity in rats · Dalinda Isabel Sánchez-Vidaña · 2019 · 101 citations · Cited by this paper
  26. Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD) · Markus Dold · 2018 · 85 citations · Cited by this paper
  27. Efficacy of Silexan in mixed anxiety–depression – A randomized, placebo-controlled trial · Siegfried F. Kasper · 2015 · 81 citations · Cited by this paper
  28. A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients · Florian Seemüller · 2023 · 71 citations · Cited by this paper
  29. Pathological fear, anxiety and negative affect exhibit distinct neurostructural signatures: evidence from psychiatric neuroimaging meta-analysis · Xiqin Liu · 2022 · 64 citations · Cited by this paper
  30. Interpretation of Statistical Significance - Exploratory Versus Confirmative Testing in Clinical Trials, Epidemiological Studies, Meta-Analyses and Toxicological Screening (Using Ginkgo biloba as an Example) · Wilhelm Gaus · 2015 · 54 citations · Cited by this paper
  31. From depression to anxiety, and back · Éric Bui · 2017 · 45 citations · Cited by this paper
  32. Beneficial effects of Silexan on sleep are mediated by its anxiolytic effect · Erich Seifritz · 2019 · 41 citations · Cited by this paper
  33. Pharmacological basis of the anxiolytic and antidepressant properties of Silexan®, an essential oil from the flowers of lavender · Walter E. Müller · 2020 · 40 citations · Cited by this paper
  34. Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy · Gijs W.E. Santen · 2009 · 39 citations · Cited by this paper
  35. Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine · Stephane Borentain · 2022 · 32 citations · Cited by this paper
  36. Item-based analysis of the effects of duloxetine in depression: a patient-level post hoc study · Alexander Lisinski · 2019 · 31 citations · Cited by this paper
  37. Neurotrophic Properties of Silexan, an Essential Oil from the Flowers of Lavender-Preclinical Evidence for Antidepressant-Like Properties · Kristina Friedland · 2020 · 29 citations · Cited by this paper
  38. Clinical relevance of depressive symptom improvement in bipolar I depressed patients · Douglas J. Williamson · 2006 · 28 citations · Cited by this paper
  39. Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant · Lysbeth L. Floden · 2022 · 18 citations · Cited by this paper

Source: OpenAlex (CC0)